Explore more publications!

Sci-Tech World Delaware: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech World Delaware.

Press releases published on October 20, 2025

Alison.ai Announces Launch of the world's first 'Creative Genome,' an Agentic AI Strategist and Video Generation Engine
All-in-One Project Management for Digital Agencies: Taskee.pro Unifies Time, Budgets, and Client Work
Proggio Unveils Timeline GPT: Disrupting Project Management by Elevating Timelines to Intelligent Fulfillment Engines
Cybernetis AI Launches Predictive Analytics Platform for Mid-Sized Retailers
NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
Constellation Software Inc. Announces Release Date for Third Quarter Results
Topicus.com Inc. Announces Release Date for Third Quarter Results
DIH Announces Fiscal 2025 Fourth Quarter and Fiscal Year End Financial Results
No Limits and Automae announce a strategic alliance to accelerate automation for SMEs in France and Switzerland
NowVertical to feature in Fireside Chat at the Planet MicroCap Showcase: TORONTO on Wednesday, October 22, 2025
3 E Network Technology Group Limited Announces Closing of US$1.5 Million Convertible Promissory Note Offering
Bio Usawa Announces Approval of BioUcenta™ by the Rwandan FDA
Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe
Commerce to Announce Third Quarter 2025 Financial Results on November 6, 2025
Onco360® Has Been Selected as a Specialty Pharmacy Partner for PHYRAGO™ (dasatinib)
CLEAR and Wellstar Health System Modernize the Patient Experience Using CLEAR1’s Digital Check-In
Cycurion, Inc. Announces Nasdaq Delisting Determination Letter
Lirum Therapeutics Announces FDA “Study May Proceed” Letter Enabling Inclusion of LX-101 in the RAPID Platform Clinical Trial for Ewing Sarcoma and Desmoplastic Small Round Cell Tumor

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions